167 related articles for article (PubMed ID: 2178236)
1. Regulation of the human neurotropic virus promoter by JCV-T antigen and HIV-1 tat protein.
Chowdhury M; Taylor JP; Tada H; Rappaport J; Wong-Staal F; Amini S; Khalili K
Oncogene; 1990 Dec; 5(12):1737-42. PubMed ID: 2178236
[TBL] [Abstract][Full Text] [Related]
2. GA/GC-rich sequence confers Tat responsiveness to human neurotropic virus promoter, JCVL, in cells derived from central nervous system.
Chowdhury M; Kundu M; Khalili K
Oncogene; 1993 Apr; 8(4):887-92. PubMed ID: 8384357
[TBL] [Abstract][Full Text] [Related]
3. Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat.
Chowdhury M; Taylor JP; Chang CF; Rappaport J; Khalili K
J Virol; 1992 Dec; 66(12):7355-61. PubMed ID: 1331525
[TBL] [Abstract][Full Text] [Related]
4. Pituitary neoplasia induced by expression of human neurotropic polyomavirus, JCV, early genome in transgenic mice.
Gordon J; Del Valle L; Otte J; Khalili K
Oncogene; 2000 Oct; 19(42):4840-6. PubMed ID: 11039901
[TBL] [Abstract][Full Text] [Related]
5. Archetype JC virus efficiently propagates in kidney-derived cells stably expressing HIV-1 Tat.
Nukuzuma S; Kameoka M; Sugiura S; Nakamichi K; Nukuzuma C; Miyoshi I; Takegami T
Microbiol Immunol; 2009 Nov; 53(11):621-8. PubMed ID: 19903262
[TBL] [Abstract][Full Text] [Related]
6. Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells.
Tada H; Rappaport J; Lashgari M; Amini S; Wong-Staal F; Khalili K
Proc Natl Acad Sci U S A; 1990 May; 87(9):3479-83. PubMed ID: 2159152
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus Tat transactivation: induction of a tissue-specific enhancer in a nonpermissive cell line.
Remenick J; Radonovich MF; Brady JN
J Virol; 1991 Oct; 65(10):5641-6. PubMed ID: 1654461
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus type-1 tat enhances interleukin-2 promoter activity through synergism with phorbol ester and calcium-mediated activation of the NF-AT cis-regulatory motif.
Vacca A; Farina M; Maroder M; Alesse E; Screpanti I; Frati L; Gulino A
Biochem Biophys Res Commun; 1994 Nov; 205(1):467-74. PubMed ID: 7999066
[TBL] [Abstract][Full Text] [Related]
9. Transduction of the human immunodeficiency virus type 1 promoter into human chromosomal DNA by adeno-associated virus: effects on promoter activity.
Nahreini P; Mathews MB
Virology; 1997 Jul; 234(1):42-50. PubMed ID: 9234945
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a mechanism of demyelination by human JC virus: negative transcriptional regulation of RNA and protein levels from myelin basic protein gene by large tumor antigen in human glioblastoma cells.
Devireddy LR; Kumar KU; Pater MM; Pater A
J Med Virol; 1996 Jul; 49(3):205-11. PubMed ID: 8818966
[TBL] [Abstract][Full Text] [Related]
11. Regulation of JCVL promoter function: evidence that a pentanucleotide "silencer" repeat sequence AGGGAAGGGA down-regulates transcription of the JC virus late promoter.
Tada H; Lashgari MS; Khalili K
Virology; 1991 Jan; 180(1):327-38. PubMed ID: 1845829
[TBL] [Abstract][Full Text] [Related]
12. Enhanced activity of human G6PD promoter transfected in HeLa cells producing high levels of HIV-1 Tat.
Ursini MV; Lettieri T; Braddock M; Martini G
Virology; 1993 Sep; 196(1):338-43. PubMed ID: 8356804
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs.
Kashanchi F; Sadaie MR; Brady JN
Virology; 1997 Jan; 227(2):431-8. PubMed ID: 9018142
[TBL] [Abstract][Full Text] [Related]
14. Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat.
Robinson D; Elliott JF; Chang LJ
Gene Ther; 1995 Jun; 2(4):269-78. PubMed ID: 7552987
[TBL] [Abstract][Full Text] [Related]
15. Dual NF1-requiring effect of human neurotropic JC virus composite pentanucleotide repeat elements on early and late viral gene expression.
Liu M; Kumar KU; Pater MM; Pater A
Virology; 1997 Jan; 227(1):7-12. PubMed ID: 9007053
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of relative promoter strengths of the HIV-1-LTR and a chimeric RSV-LTR in T lymphocytic cells and peripheral blood mononuclear cells: promoters for anti-HIV-1 gene therapies.
Mukhtar M; Duan L; Bagasra O; Pomerantz RJ
Gene Ther; 1996 Aug; 3(8):725-30. PubMed ID: 8854098
[TBL] [Abstract][Full Text] [Related]
17. Identification of a cellular protein that binds to Tat-responsive element of TGF beta-1 promoter in glial cells.
Thatikunta P; Sawaya BE; Denisova L; Cole C; Yusibova G; Johnson EM; Khalili K; Amini S
J Cell Biochem; 1997 Dec; 67(4):466-77. PubMed ID: 9383706
[TBL] [Abstract][Full Text] [Related]
18. Human polyomavirus JCV late leader peptide region contains important regulatory elements.
Akan I; Sariyer IK; Biffi R; Palermo V; Woolridge S; White MK; Amini S; Khalili K; Safak M
Virology; 2006 May; 349(1):66-78. PubMed ID: 16497349
[TBL] [Abstract][Full Text] [Related]
19. The human immunodeficiency virus long terminal repeat includes a specialised initiator element which is required for Tat-responsive transcription.
Rittner K; Churcher MJ; Gait MJ; Karn J
J Mol Biol; 1995 May; 248(3):562-80. PubMed ID: 7752225
[TBL] [Abstract][Full Text] [Related]
20. Regulation of JCVL promoter function: transactivation of JCVL promoter by JCV and SV40 early proteins.
Lashgari MS; Tada H; Amini S; Khalili K
Virology; 1989 May; 170(1):292-5. PubMed ID: 2541545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
